Spero Therapeutics
SPRO
SPRO
78 hedge funds and large institutions have $186M invested in Spero Therapeutics in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
3% less funds holding
Funds holding: 80 → 78 (-2)
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
65% less call options, than puts
Call options by funds: $217K | Put options by funds: $614K
Holders
78
Holding in Top 10
2
Calls
$217K
Puts
$614K
Top Buyers
| 1 | +$28.5M | |
| 2 | +$9.57M | |
| 3 | +$6.93M | |
| 4 |
AIC
AWM Investment Company
New York
|
+$2.85M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.32M |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$699K | |
| 3 | -$597K | |
| 4 |
Two Sigma Investments
New York
|
-$381K |
| 5 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$375K |